ONCY Stock Analysis: Buy, Sell, or Hold?
ONCY - Oncolytics Biotech, Inc. Common Shares
$0.80
-0.01 (-1.49%)
▼
5d:
-5.87%
30d:
-13.06%
90d:
-22.32%
HOLD
MODERATE Confidence
Analysis Updated: Jul 27, 2026 12:00 AM ET
Earnings: Aug 14, 2026
16d
Get Alerted When ONCY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ONCY shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ONCY shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ONCY is currently trading at $0.80, which is considered oversold relative to its 30-day fair value range of $0.84 to $0.94.
Technical Outlook: Technically, ONCY is in a downtrend. The price is currently testing key support at $0.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ONCY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.06 (+531.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ONCY is in a downtrend. The price is currently testing key support at $0.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ONCY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.06 (+531.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.84 -
$0.94
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 531.9% below Wall St target ($5.06)
- CAUTION: 5-day price weakness (-5.9%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.84 -
$0.94
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.80
Resistance Level
$0.96
Current Trend
Downtrend
Technical data as of
Jul 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.37
Wall Street Target
$5.06
(+531.9%)
Share & Embed Analysis
Last updated: July 28, 2026 1:19 AM ET
Data refreshes hourly during market hours. Next update: 2:19 AM
Data refreshes hourly during market hours. Next update: 2:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ONCY showing a specific setup today?
Insider Activity (6 Months)
13
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jared Kelly
BUY
5050 shares
2026-03-12
James T Parsons
BUY
10000 shares
2026-03-11
Allison Hagerman
BUY
10000 shares
2026-02-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$283 | 64 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 58 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$115 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 46 HOLD |
